Let's Connect

News

The Best Medication Is the One Patients Take: Weighing Augmentation Risks

By Industry News 1 min read

​Modest efficacy gains from switching push many clinicians toward augmentation instead. The panel weighs guideline thresholds, side-effect-driven medication matching, and the polypharmacy risks that complicate adding a second agent.  — From Psychiatric Times articles Read More

Share this post
All News posts
News Industry News 10:00 am Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia ​Explore how OCD and schizophrenia overlap, complicating diagnosis and care, and learn spectrum-based strategies and treatment pitfalls for managing schizo-obsessive symptoms.  — From Psychiatric Times articles Read More News Industry News 9:00 am A Veterans Day Salute: Lessons From 1918 and 2026 for Psychiatrists ​Psychiatric Times honors those who served with reflections from a World War I diary and new studies on veteran PTSD and suicide risk.  — From Psychiatric Times articles Read More News Industry News 9:00 am Preventing Schizophrenia Relapse in Women: What You Need to Know ​How estrogen dips during menstruation, pregnancy, postpartum, and menopause can trigger schizophrenia relapse, and what it means for antipsychotic dosing.  — From Psychiatric Times articles Read More

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Follow us

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.